ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,258Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 34

$740K Total Retail Price of All Prescriptions

Rank: 5 out of 34

653 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Rhode Island
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 653 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $135 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
HYDROCHLOROTHIAZIDE 720 682 97 1 14
ATORVASTATIN CALCIUM 685 668 99 2 10
AMLODIPINE BESYLATE 642 624 90 3 13
LEVOTHYROXINE SODIUM 521 496 75 4 15
OMEPRAZOLE 486 445 71 5 7
LOSARTAN POTASSIUM 416 404 55 6 18
METOPROLOL TARTRATE 406 390 59 7 16
SPIRIVA 401 371 72 8 1
LISINOPRIL 377 353 56 9 9
SIMVASTATIN 367 336 59 10 12
PRAVASTATIN SODIUM 354 337 49 11 21
PROAIR HFA 318 294 105 12 3
FUROSEMIDE 314 288 53 13 8
ADVAIR DISKUS 262 249 57 14 2
ATENOLOL 248 232 32 15 24
FLUTICASONE PROPIONATE 227 205 93 16 11
ENALAPRIL MALEATE 213 213 29 17 29
METFORMIN HCL 199 184 31 18 25
MONTELUKAST SODIUM 169 164* 27 19 4
FLOVENT HFA 148 143* 42 20 17
CRESTOR 135 130* 19 21 49
METOPROLOL SUCCINATE 126 126 20 22 44
DIOVAN 125 125 20 23 52
GEMFIBROZIL 121 121 14 24 76
RANITIDINE HCL 117 99 20 25 42
METFORMIN HCL ER 115 110* 15 26 41
PANTOPRAZOLE SODIUM 114 109* 16 27 33
LORAZEPAM 112 112 22 B 28 39
SYMBICORT 112 89 30 28 6
CLOPIDOGREL 108 108 13 30 35
WARFARIN SODIUM 104 104 27 31 51
GLIPIZIDE 100 95* 11 32 88
ALLOPURINOL 97 92* 17 33 45
COMBIVENT RESPIMAT 89 66 36 34 26
DILTIAZEM 24HR ER 79 <11 <11 35 55
COMBIVENT 75 70* 37 36 38
PREDNISONE 74 69* 40 37 5
LOVASTATIN 73 73 11 38 31
KLOR-CON 10 73 <11 <11 38 92
ISOSORBIDE MONONITRATE ER 73 <11 <11 38 92
KLOR-CON M20 71 66* 12 41 71
SYNTHROID 69 69 11 42 54
NEXIUM 69 <11 <11 42 60
CITALOPRAM HBR 68 68 11 44 37
SERTRALINE HCL 68 <11 <11 44 32
POTASSIUM CHLORIDE 65 65 13 46 98
TRAMADOL HCL 65 <11 <11 46 59
FLUOXETINE HCL 63 58* 13 48 61
VERAPAMIL ER 63 <11 <11 48 57
DULERA 63 58* 22 48 46
PAROXETINE HCL 62 <11 <11 51 68
ALPRAZOLAM 59 54* 12 B 52 30
HYDROCODONE-ACETAMINOPHEN 58 <11 <11 S3 53 23
QUINAPRIL HCL 57 <11 <11 54 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 <11 <11 55 81
METHYLPREDNISOLONE 55 50* 40 56 67
FLUVASTATIN SODIUM 55 <11 <11 10 56 107
FAMOTIDINE* 52 <11 <11 58 112
RAMIPRIL 51 <11 <11 59 114
TRIAMTERENE-HCTZ 50 <11 <11 60 80
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.